top of page
WhiteText_withSlogan_withTransparentPicture_emailSignatureArtboard 1_2x_edited.png

About Us

Biotech on a mission to orchestrate the body's own regeneration capabilities

"The most remarkable discovery made by scientists is science itself."

Jacob Bronowski

The Future of Healthcare: Our Commitment to Regenerative Medicine and Tissue Engineering

OrganoGEN Limited is a leading provider of regenerative medicine services in Cyprus.

Our team is dedicated to helping patients achieve optimal health and wellness through the use of innovative regenerative medicine techniques. Our body has the natural ability to heal itself, but sometimes due to traumas or aging related diseases, this ability is impaired. Our goal is to support and enhance the healing process of the human body utilising the multidisciplinary sciences of Regenerative Medicine and Tissue Engineering.

Our team is made up of highly trained and experienced medical professionals, including our founder and CEO of the company Dr. Andreas Samourides. Andreas has a doctoral degree in Regenerative Medicine and Tissue Engineering, with experience in producing and co-applying autologous cell therapies as well as in developing biomimetic scaffolds for skin, oral mucosa, tendon and bone tissue engineering. The unique scientific, clinical and technical capabilities of OrganoGEN is the key for achieving the company's mission, to offer:

  • The best Regenerative Medicine technologies to medical providers

  • Produce and control the therapeutic product following proper regenerative medicine practices to ensure that our patients receive the appropriate treatment

  • Support the medical providers with patient specific treatment consultation and optimised regenerative medicine protocols

  • Be ethical on the use and advertisement of the products and services we offer, to avoid misleading our clients and patients with overpromises and fake treatments

  • Help the industry to grow by actively participating in R&D activities

We are committed to staying at the forefront of the industry, and we are constantly researching and exploring new and emerging regenerative medicine technologies. At OrganoGEN, we take a personalized and holistic approach to patient care. We work closely with the medical providers for each of their patient to understand their unique needs and goals, and we develop customized treatment plans that address their specific health concerns.

We have strong working relationships with medical providers in Cyprus, and we are proud to be a trusted resource for their patients. We believe that good communication and coordination between healthcare professionals is essential for providing the highest quality care to patients, and we are committed to working closely with medical providers to ensure that our patients receive the best possible care.

OrganoGEN is also actively involved in Research & Development (R&D) for producing autologous therapeutic agents and synthetic scaffolds (patent pending)  for tissue engineering. We have access to state-of-the-art research facilities through our excellent collaboration with the Cyprus University of Technology, of which with the help of Research & Innovation Foundation of Cyprus, Vet ex Machina, and others we developed and proven our innovative R&D project in pre-clinical models. More research is being conducted to continue our journey towards clinical development.

Thank you for considering us for your regenerative medicine needs. We are confident that our team can help you achieve optimal health and wellness, and we look forward to the opportunity to work with you.

Contact us today to set up a meeting.​

bottom of page